Correspondence 0001493152-23-027027 from Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: Aug. 7, 2023 · CIK: 0001106838 · Accession: 0001493152-23-027027
AI Filing Summary & Sentiment
File numbers found in text: 333-273516
Letter
Re: Sonnet BioTherapeutics Holdings, Inc. (the “Company”)
August 7, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1 (File No. 333-273516)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m. Eastern Time on August 9, 2023, or as soon thereafter as is practicable.
Please call Alexander E. Dinur of Lowenstein Sandler LLP at 973-422-6732 to confirm the effectiveness of the Registration Statement or with any questions.
Sincerely,
Sonnet
BioTherapeutics Holdings, Inc.
Show Raw Text
CORRESP
1
filename1.htm
August
7, 2023
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Sonnet BioTherapeutics Holdings, Inc. (the “Company”)
Registration
Statement on Form S-1 (File No. 333-273516)
Ladies
and Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the effective date for the Registration
Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m. Eastern Time on August 9, 2023, or as soon
thereafter as is practicable.
Please
call Alexander E. Dinur of Lowenstein Sandler LLP at 973-422-6732 to confirm the effectiveness of the Registration Statement or with
any questions.
Sincerely,
Sonnet
BioTherapeutics Holdings, Inc.
By:
/s/
Pankaj Mohan, Ph.D.
Name:
Pankaj
Mohan, Ph.D.
Title:
Chief
Executive Officer